Your session is about to expire
← Back to Search
Other
Ketogenic Diet for Schizophrenia
N/A
Recruiting
Led By Deanna L Kelly, Pharm.D., BCPP
Research Sponsored by University of Maryland, Baltimore
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights
Study Summary
This trial finds that a ketogenic diet may be as effective as antipsychotic drugs in treating schizophrenia, with potential additional benefits on metabolic outcomes.
Who is the study for?
Adults aged 18-64 with schizophrenia or schizoaffective disorder, stable on antipsychotics for at least two weeks, and a BMI over 18.5 can join this trial. They must score sufficiently on tests to show they understand the consent process. Excluded are pregnant women, those with severe heart, kidney or liver issues, certain metabolic disorders, eating disorders or alcohol use disorder.Check my eligibility
What is being tested?
This study is testing whether a ketogenic diet (high fat, low carb) helps improve symptoms of schizophrenia compared to a regular diet. It's designed as a double-blind controlled trial but hasn't been done before due to challenges in monitoring food intake in patients.See study design
What are the potential side effects?
Potential side effects from the ketogenic diet may include digestive discomforts like constipation or diarrhea initially, possible nutrient deficiencies if not monitored properly and changes in blood lipid levels.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 3 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Assessment of positive and negative symptoms
Trial Design
2Treatment groups
Active Control
Placebo Group
Group I: Ketogenic DietActive Control1 Intervention
Group II: Regular DietPlacebo Group1 Intervention
Find a Location
Who is running the clinical trial?
University of Maryland, BaltimoreLead Sponsor
688 Previous Clinical Trials
374,606 Total Patients Enrolled
66 Trials studying Schizophrenia
10,207 Patients Enrolled for Schizophrenia
Deanna L Kelly, Pharm.D., BCPPPrincipal InvestigatorStudy Principal Investigator
3 Previous Clinical Trials
586 Total Patients Enrolled
3 Trials studying Schizophrenia
586 Patients Enrolled for Schizophrenia
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have a serious kidney condition.I have been diagnosed with schizophrenia or schizoaffective disorder.I have diabetes and need insulin.I have been diagnosed with an eating disorder.I have heart failure.I have a serious liver condition.My antipsychotic medication dose has been stable for the last 14 days.I scored 10 or higher on a test to show I understand the consent form.I may have early signs of kidney injury or moderate kidney disease.I have a history of liver disease.I have been diagnosed with gastroparesis.I am between 18 and 64 years old.
Research Study Groups:
This trial has the following groups:- Group 1: Regular Diet
- Group 2: Ketogenic Diet
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Does the age range for this trial extend to individuals below 45 years of age?
"This trial is looking for applicants between 18 to 64 years old. There are 105 alternative trials designed for minors and 256 studies oriented towards the elderly population."
Answered by AI
May I partake in this research endeavor?
"Qualified applicants with schizophrenia, aged 18-64 years old, may join this research study; approximately 50 participants are sought."
Answered by AI
Are there still opportunities for participants to join this clinical trial?
"Reports on clinicaltrials.gov indicate that this research is not presently accepting applicants, despite being posted 8/1/2023 and edited 7/26/2023. Nevertheless, there are 510 other trials currently seeking participants."
Answered by AI
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger